No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Amoebiasis is a parasitic infection caused by the protozoan Entamoeba histolytica. It is a common cause of diarrhea and dysentery in tropical and subtropical regions. Treatment of amoebiasis is typically done with drugs that target the parasite, such as metronidazole, tinidazole, and iodoquinol. These drugs are part of the larger infectious diseases drugs market, which includes treatments for a variety of bacterial, viral, and parasitic infections.
The amoebiasis drug market is a subset of the infectious diseases drugs market, and is composed of drugs that specifically target the parasite Entamoeba histolytica. These drugs are used to treat the symptoms of amoebiasis, such as diarrhea and dysentery. The market is composed of both generic and branded drugs, and is highly competitive.
Some companies in the amoebiasis drug market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more
